Fundraising Fox

Accelerate Diagnostics

Tucson, US · Delaware corporation

Biotech

Founders & leadership

LM
Lawrence MehrenExecutive
PB
Pete BantockExecutive
FJ
Frank J.M. ten BrinkNamed on SEC filing
TD
Thomas D. BrownNamed on SEC filing
MC
Mark C. MillerNamed on SEC filing
CW
Charles WattsNamed on SEC filing
RP
Ron PriceNamed on SEC filing
HM
Hany MassaranyNamed on SEC filing
JJ
John J. PhillipsNamed on SEC filing
SR
Steve ReichlingNamed on SEC filing

Board

MW
Matthew W. StrobeckBoard director
JP
John PatienceBoard director

Reported raises · per SEC filings

Form D private placements

$56.5M disclosed across 5 rounds · 2014–2022

▶$4MraisedApr 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John PatienceDirector
  • Hany MassaranyDirector
  • Charles WattsDirector
  • Mark C. MillerDirector
  • Frank J.M. ten BrinkDirector
  • Louise L. FrancesconiDirector
  • Jack SchulerDirector
  • John J. PhillipsExecutive Officer, Director
  • Ron PriceExecutive Officer
  • Steve ReichlingExecutive Officer
  • Thomas D. BrownDirector
  • Wayne C. BurrisDirector
  • Matthew W. StrobeckDirector
Offering amount
$4M
Amount sold
$4M
First sale
Mar 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedSep 2021 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Louise L. FrancesconiDirector
  • Matthew W. StrobeckDirector
  • John PatienceDirector
  • Frank J.M. ten BrinkDirector
  • Thomas D. BrownDirector
  • Mark C. MillerDirector
  • Charles WattsDirector
  • Ron PriceExecutive Officer
  • Hany MassaranyDirector
  • Jack SchulerDirector
  • John J. PhillipsExecutive Officer, Director
  • Steve ReichlingExecutive Officer
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.4MraisedSep 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron PriceExecutive Officer
  • Matthew W. StrobeckDirector
  • Thomas D. BrownDirector
  • John PatienceDirector
  • John J. PhillipsExecutive Officer, Director
  • Mark C. MillerDirector
  • Jack SchulerDirector
  • Louise L. FrancesconiDirector
  • Hany MassaranyDirector
  • Frank J.M. ten BrinkDirector
  • Steve ReichlingExecutive Officer
  • Charles WattsDirector
Offering amount
$30.4M
Amount sold
$30.4M
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1000KraisedAug 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles WattsDirector
  • Jack SchulerDirector
  • Ron PriceExecutive Officer
  • John J. PhillipsExecutive Officer
  • Frank J.M. ten BrinkDirector
  • Matthew W. StrobeckDirector
  • Romney HumphriesExecutive Officer
  • John PatienceDirector
  • Mark C. MillerDirector
  • Lawrence MehrenExecutive Officer, Director
  • Thomas D. BrownDirector
  • Steve ReichlingExecutive Officer
Offering amount
$1000K
Amount sold
$1000K
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.5MraisedJun 2014 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve ReichlingExecutive Officer
  • John PatienceDirector
  • Lawrence MehrenExecutive Officer, Director
  • Pete BantockExecutive Officer
  • Matthew W. Strobeck, Ph.DDirector
  • Mark C. MillerDirector
  • Jack SchulerDirector
  • Frank J.M. ten BrinkDirector
Offering amount
$19.5M
Amount sold
$19.5M
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Accelerate Diagnostics raised?
Accelerate Diagnostics has disclosed $56.5M raised across 5 rounds.
Where is Accelerate Diagnostics headquartered?
Accelerate Diagnostics is headquartered in Tucson, US.